Journals / Journal of Health Sciences and Medicine / 2026 / Volume: 9 Issue: 6

Acute illness severity outweighs comorbidity in predicting 30-day mortality after percutaneous endoscopic gastrostomy in critically ill patients

Engin Çetin(Kocaeli Şehir Hastanesi)0000-0002-3011-3968
Ali Hakan Emirkadı(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL SULTAN ABDÜLHAMİD HAN SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0001-6938-0476
Pages
—
Publication Date
2026-10-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Acute physiology, nutritional reserve and haemodynamic stability carried the prognostic weight.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: To determine whether the Charlson Comorbidity Index (CCI) independently predicts 30-day mortality after percutaneous endoscopic gastrostomy (PEG) in intensive care unit (ICU) patients, to compare it with acute illness severity measured at admission and on the day of the procedure, and to relate the interval between ICU admission and PEG to early outcome.
📊
Key Findings & Data:Methods: This single-centre retrospective cohort included adult ICU patients undergoing PEG between June 2023 and June 2026.
💡
Conclusion & Impact:Acute physiology, nutritional reserve and haemodynamic stability carried the prognostic weight.
🔬Design:Modeling & Simulation
📍Scope:2023 Verileri
⚙️Variables:Percutaneous endoscopic gastrostomy · intensive care units · comorbidity

Abstract

Aims: To determine whether the Charlson Comorbidity Index (CCI) independently predicts 30-day mortality after percutaneous endoscopic gastrostomy (PEG) in intensive care unit (ICU) patients, to compare it with acute illness severity measured at admission and on the day of the procedure, and to relate the interval between ICU admission and PEG to early outcome. Methods: This single-centre retrospective cohort included adult ICU patients undergoing PEG between June 2023 and June 2026. The primary endpoint was death within 30 days. Comorbidities, Acute Physiology and Chronic Health Evaluation (APACHE-II) and Sequential Organ Failure Assessment (SOFA) scores at admission, SOFA on the day of PEG, organ support and laboratory data were taken from records. Logistic regression, Kaplan-Meier analysis, Cox models and receiver operating characteristic analysis were used. Results: Of 334 patients, 143 (42.8%) died within 30 days. PEG was performed a median of 5 days (interquartile range 3-12) after ICU admission and death a median of 10 days later. The CCI was associated with mortality univariably but not after adjustment (adjusted odds ratio 0.960, p=0.571). The PEG-day SOFA score predicted mortality univariably (odds ratio 1.243, p<0.001) but was not independent and discriminated less well than the admission score (area under the curve 0.704 versus 0.741, p=0.003). Independent predictors were higher APACHE-II or admission SOFA scores, lower albumin and vasopressor requirement. A shorter admission-to-PEG interval was also associated with early death. Conclusion: Comorbidity burden was not independently associated with 30-day mortality after PEG. Acute physiology, nutritional reserve and haemodynamic stability carried the prognostic weight.

🔖

Cite This Article

Çetin, E., Emirkadı, A. H. (2026). Acute illness severity outweighs comorbidity in predicting 30-day mortality after percutaneous endoscopic gastrostomy in critically ill patients. Journal of Health Sciences and Medicine, Volume: 9 Issue: 6. https://ajindex.com/articles/1668048

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. Tae CH, Lee JY, Joo MK, et al. Clinical practice guideline for percutaneous endoscopic gastrostomy. Gut Liver. 2024;18(1):10-26. doi:10.5009/gnl230146
  2. Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol. 2014;20(24):7739-7751. doi:10.3748/wjg.v20.i24.7739
  3. Janes SEJ, Price CSG, Khan S. Percutaneous endoscopic gastrostomy: 30-day mortality trends and risk factors. J Postgrad Med. 2005;51(1):23-28.
  4. Kobayashi K, Cooper GS, Chak A, Sivak MV Jr, Wong RCK. A prospective evaluation of outcome in patients referred for PEG placement. Gastrointest Endosc. 2002;55(4):500-506. doi:10.1067/mge.2002.122577
  5. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. doi:10.1016/0021-9681(87)90171-8
  6. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676-682. doi:10.1093/aje/kwq433
  7. Friedenberg F, Jensen G, Gujral N, Braitman LE, Levine GM. Serum albumin is predictive of 30-day survival after percutaneous endoscopic gastrostomy. J Parenter Enteral Nutr. 1997;21(2):72-74. doi:10.1177/014860719702100272
  8. Duzenli T, Ketenci M, Akyol T, et al. Predictive factors of complications and 30-day mortality in patients undergoing percutaneous endoscopic gastrostomy: the utility of C-reactive protein to albumin ratio. Acta Gastroenterol Belg. 2021;84(2):283-288. doi:10.51821/84.2.283
  9. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754-1758. doi:10.1001/jama.286.14.1754
  10. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-349. doi:10.1016/j.jclinepi.2007.11.008
  11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829. doi:10.1097/00003246-198510000-00009
  12. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22(7):707-710. doi:10.1007/BF01709751
  13. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-845. doi:10.2307/2531595
  14. Anderloni A, Di Leo M, Barzaghi F, et al. Complications and early mortality in percutaneous endoscopic gastrostomy placement in Lombardy: a multicenter prospective cohort study. Dig Liver Dis. 2019;51(10):1380-1387. doi:10.1016/j.dld.2019.03.024
  15. Abuksis G, Mor M, Segal N, et al. Percutaneous endoscopic gastrostomy: high mortality rates in hospitalized patients. Am J Gastroenterol. 2000;95(1):128-132. doi:10.1111/j.1572-0241.2000.01672.x
  16. Stenberg K, Eriksson A, Odensten C, Darehed D. Mortality and complications after percutaneous endoscopic gastrostomy: a retrospective multicentre study. BMC Gastroenterol. 2022;22(1):361. doi:10.1186/s12876-022-02429-0
  17. Sezer S, Aytaç Ş. Predictors of early mortality after percutaneous endoscopic gastrostomy in geriatric patients. Eur J Geriatr Gerontol. 2025;7(1):6-10. doi:10.4274/ejgg.galenos.2025.2024-12-3
  18. Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol. 2008;167(4):492-499. doi:10.1093/aje/kwm324
  19. Young D, Harrison DA, Cuthbertson BH, Rowan K; TracMan Collaborators. Effect of early vs late tracheostomy placement on survival in patients receiving mechanical ventilation: the TracMan randomized trial. JAMA. 2013;309(20):2121-2129. doi:10.1001/jama.2013.5154
  20. Lima DL, Miranda LEC, Lima RNCL, et al. Factors associated with mortality after percutaneous endoscopic gastrostomy. JSLS. 2023;27(2):e2023.00005. doi:10.4293/JSLS.2023.00005
  21. Arora G, Rockey D, Gupta S. High in-hospital mortality after percutaneous endoscopic gastrostomy: results of a nationwide population-based study. Clin Gastroenterol Hepatol. 2013;11(11):1437-1444.e3. doi:10.1016/j.cgh.2013.04.011
  22. Topçu H, Sezikli İ, Tutan D, Köseoğlu H, Topcu R. Assessment of factors affecting mortality in patients with percutaneous endoscopic gastrostomy tube placement in the intensive care unit. J Med Palliat Care. 2023;4(1):34-40. doi:10.47582/jompac.1217112
  23. Mutlu Bilgiç N, Kahveci G, Aykut H, Özer Y, Özşenel EB, Basat S. Risk factors for complications and 90-day mortality after percutaneous endoscopic gastrostomy: the role of nutritional and inflammatory markers. Medicina (Kaunas). 2025;61(11):1916. doi:10.3390/medicina61111916
  24. Yeşiltaş S, Güzel C, Sümer İ, et al. The effect of exogenous human albumin administration on acute kidney injury development in hypoalbuminemic patients in the intensive care unit. Bezmialem Science. 2022;10(2):144-149. doi:10.14235/bas.galenos.2021.6113
  25. Sviri S, Hashoul J, Stav I, van Heerden PV. Does high-dose vasopressor therapy in medical intensive care patients indicate what we already suspect? J Crit Care. 2014;29(1):157-160. doi:10.1016/j.jcrc.2013.09.004